Mutual of America Capital Management LLC Has $10.56 Million Holdings in CME Group Inc. $CME

Mutual of America Capital Management LLC trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 5.5% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 39,065 shares of the financial services provider’s stock after selling 2,261 shares during the period. Mutual of America Capital Management LLC’s holdings in CME Group were worth $10,555,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CME. Caldwell Trust Co increased its holdings in shares of CME Group by 116.3% during the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 50 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new stake in CME Group during the third quarter worth approximately $27,000. Financial Consulate Inc. bought a new stake in CME Group during the third quarter worth approximately $28,000. Sagard Holdings Management Inc. acquired a new position in CME Group during the second quarter valued at approximately $30,000. Finally, Corundum Trust Company INC bought a new position in shares of CME Group in the third quarter valued at approximately $30,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

NASDAQ CME opened at $284.05 on Tuesday. The company has a 50 day moving average of $274.27 and a 200-day moving average of $271.98. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1-year low of $232.32 and a 1-year high of $290.79. The firm has a market cap of $102.43 billion, a price-to-earnings ratio of 27.52, a PEG ratio of 3.20 and a beta of 0.27.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Friday, December 12th. CME Group’s dividend payout ratio is presently 48.45%.

Wall Street Analysts Forecast Growth

CME has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CME Group from $310.00 to $318.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Weiss Ratings reiterated a “buy (b+)” rating on shares of CME Group in a research report on Monday, December 29th. The Goldman Sachs Group lowered their price target on shares of CME Group from $265.00 to $264.00 and set a “sell” rating on the stock in a report on Wednesday, January 14th. Jefferies Financial Group reduced their price objective on shares of CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a report on Monday, January 12th. Finally, UBS Group reiterated a “neutral” rating on shares of CME Group in a research report on Tuesday, January 6th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $292.18.

Insider Buying and Selling at CME Group

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of CME Group stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the sale, the director directly owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William R. Shepard acquired 251 shares of the stock in a transaction that occurred on Tuesday, December 30th. The stock was purchased at an average price of $278.37 per share, with a total value of $69,870.87. Following the completion of the transaction, the director owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.